Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.

Rigato PO, de Alencar BC, de Vasconcelos JR, Dominguez MR, Araújo AF, Machado AV, Gazzinelli RT, Bruna-Romero O, Rodrigues MM.

Infect Immun. 2011 May;79(5):2120-30. doi: 10.1128/IAI.01190-10. Epub 2011 Feb 28.

2.

Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.

Miyahira Y.

Parasitol Int. 2008 Mar;57(1):38-48. Epub 2007 Aug 1. Review. Erratum in: Parasitol Int. 2008 Jun;57(2):242.

PMID:
17728174
3.

Advances and challenges towards a vaccine against Chagas disease.

Quijano-Hernandez I, Dumonteil E.

Hum Vaccin. 2011 Nov;7(11):1184-91. doi: 10.4161/hv.7.11.17016. Epub 2011 Nov 1. Review.

4.

Strategies and implications for prime-boost vaccination to generate memory CD8 T cells.

Nolz JC, Harty JT.

Adv Exp Med Biol. 2011;780:69-83. doi: 10.1007/978-1-4419-5632-3_7. Review.

PMID:
21842366
5.

CD8+ T cells in Trypanosoma cruzi infection.

Padilla AM, Bustamante JM, Tarleton RL.

Curr Opin Immunol. 2009 Aug;21(4):385-90. doi: 10.1016/j.coi.2009.07.006. Epub 2009 Jul 29. Review.

6.

CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?

Dos Santos Virgilio F, Pontes C, Dominguez MR, Ersching J, Rodrigues MM, Vasconcelos JR.

Mediators Inflamm. 2014;2014:243786. doi: 10.1155/2014/243786. Epub 2014 Jul 1. Review.

7.

CD8+ T cells in Trypanosoma cruzi infection.

Tarleton RL.

Semin Immunopathol. 2015 May;37(3):233-8. doi: 10.1007/s00281-015-0481-9. Epub 2015 Apr 29. Review.

8.

Vaccine development against Trypanosoma cruzi and Chagas disease.

Vázquez-Chagoyán JC, Gupta S, Garg NJ.

Adv Parasitol. 2011;75:121-46. doi: 10.1016/B978-0-12-385863-4.00006-X. Review.

PMID:
21820554
9.

Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.

Sánchez-Valdéz FJ, Pérez Brandán C, Ferreira A, Basombrío MÁ.

Expert Rev Vaccines. 2015 May;14(5):681-97. doi: 10.1586/14760584.2015.989989. Epub 2014 Dec 11. Review.

PMID:
25496192
10.

Prophylactic and therapeutic DNA vaccines against Chagas disease.

Arce-Fonseca M, Rios-Castro M, Carrillo-Sánchez Sdel C, Martínez-Cruz M, Rodríguez-Morales O.

Parasit Vectors. 2015 Feb 24;8:121. doi: 10.1186/s13071-015-0738-0. Review.

11.

Experimental Vaccines against Chagas Disease: A Journey through History.

Rodríguez-Morales O, Monteón-Padilla V, Carrillo-Sánchez SC, Rios-Castro M, Martínez-Cruz M, Carabarin-Lima A, Arce-Fonseca M.

J Immunol Res. 2015;2015:489758. doi: 10.1155/2015/489758. Epub 2015 May 18. Review.

12.

The multifaceted role of CD4(+) T cells in CD8(+) T cell memory.

Laidlaw BJ, Craft JE, Kaech SM.

Nat Rev Immunol. 2016 Feb;16(2):102-11. doi: 10.1038/nri.2015.10. Epub 2016 Jan 19. Review.

13.

Influence of time and number of antigen encounters on memory CD8 T cell development.

Martin MD, Badovinac VP.

Immunol Res. 2014 Aug;59(1-3):35-44. doi: 10.1007/s12026-014-8522-3. Review.

PMID:
24825776
14.

Regulation of CD8+ T cell responses to infection with parasitic protozoa.

Jordan KA, Hunter CA.

Exp Parasitol. 2010 Nov;126(3):318-25. doi: 10.1016/j.exppara.2010.05.008. Epub 2010 May 21. Review.

15.

Immunologic considerations for generating memory CD8 T cells through vaccination.

Butler NS, Nolz JC, Harty JT.

Cell Microbiol. 2011 Jul;13(7):925-33. doi: 10.1111/j.1462-5822.2011.01594.x. Epub 2011 Apr 28. Review.

16.

The interface between transcriptional and epigenetic control of effector and memory CD8⁺ T-cell differentiation.

Gray SM, Kaech SM, Staron MM.

Immunol Rev. 2014 Sep;261(1):157-68. doi: 10.1111/imr.12205. Review.

17.

Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects.

Dumonteil E, Bottazzi ME, Zhan B, Heffernan MJ, Jones K, Valenzuela JG, Kamhawi S, Ortega J, de Leon Rosales SP, Lee BY, Bacon KM, Fleischer B, Slingsby BT, Cravioto MB, Tapia-Conyer R, Hotez PJ.

Expert Rev Vaccines. 2012 Sep;11(9):1043-55. doi: 10.1586/erv.12.85. Review.

19.

DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1.

Agadjanyan MG, Wang B, Nyland SB, Weiner DB, Ugen KE.

Curr Top Microbiol Immunol. 1998;226:175-92. Review. No abstract available.

PMID:
9479842
20.

Memory CD8 T cell transcriptional plasticity.

Youngblood B, Hale JS, Ahmed R.

F1000Prime Rep. 2015 Apr 1;7:38. doi: 10.12703/P7-38. eCollection 2015. Review.

Supplemental Content

Support Center